Therapeutic options in coronary artery disease: focusing on the guidelines

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Medicine

Background:

• Coronary artery disease (CAD) management involves three primary strategies: coronary artery bypass graft surgery (CABG), percutaneous coronary intervention (PCI), and optimal medical treatment (OMT) alone.
• While CABG and PCI have seen significant advancements and utilization, OMT's efficacy has been consistently demonstrated in randomized trials.
• OMT remains a crucial component in studies like the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Purpose of the Study:

• To compare the effectiveness of CABG, PCI, and OMT for patients with acute and chronic coronary syndromes.
• To outline the indications for each treatment modality based on current American College of Cardiology and American Heart Association guidelines.

Main Methods:

• Review of existing literature and clinical trial data comparing CABG, PCI, and OMT.
• Analysis of treatment guidelines from major cardiology organizations.
• Comparison of outcomes in acute versus chronic coronary syndromes.

Main Results:

• Optimal medical treatment alone demonstrates significant effectiveness in managing coronary artery disease.
• Revascularization procedures (CABG and PCI) are increasingly used, particularly PCI for multivessel disease in some regions like Canada.
• Prognostic benefits for revascularization are limited to specific subsets of patients, especially in chronic coronary syndromes.

Conclusions:

• Optimal medical treatment is a highly effective and often underemphasized approach for coronary artery disease.
• Revascularization decisions should be guided by comprehensive guidelines, considering that OMT alone is often sufficient.
• Indications for revascularization based on prognosis alone are rare, particularly in chronic coronary syndromes.